On January 4, Cutis-Biotech, a pharmacertical firm, filed a suit in the civil court claiming it was a prior user of the brandname Covishield, and sought to restrain SII from using the name. SII is producing a coronavirus vaccine named Covishield, co-developed by the University of Oxford and British-Swedish company AstraZeneca.
from Zee News :India National https://ift.tt/2MG8NJD
via IFTTT
Saturday, January 30, 2021
Pune court rejects trademark-violation plea against Serum Institute over `Covishield` https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment